Financial reports
10-K/A
2023 FY
Annual report (amended)
11 Mar 24
10-K
2023 FY
Annual report
27 Feb 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
14 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
Current reports
8-K
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
18 Apr 24
8-K
Longeveron Announces Pricing of $5.25 Million Public Offering
11 Apr 24
8-K
Longeveron Announces 1-for-10 Reverse Stock Split
19 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6 Mar 24
8-K
Submission of Matters to a Vote of Security Holders
22 Feb 24
8-K
Submission of Matters to a Vote of Security Holders
28 Dec 23
8-K
UPDATE -- Longeveron Announces $2.36 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
22 Dec 23
8-K
Longeveron Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
13 Oct 23
8-K
Longeveron Announces Positive Top-Line Results for Lomecel-BTM in its CLEAR MIND Phase 2a Clinical Trial in the Treatment of Mild Alzheimer’s Disease
5 Oct 23
8-K
Other Events
25 Sep 23
Registration and prospectus
D
$12.42 mm in options / securities to be acquired, 3 investors
25 Apr 24
424B4
Prospectus supplement with pricing info
17 Apr 24
S-1/A
IPO registration (amended)
16 Apr 24
424B3
Prospectus supplement
10 Apr 24
424B4
Prospectus supplement with pricing info
10 Apr 24
FWP
Free writing prospectus
8 Apr 24
S-1/A
IPO registration (amended)
5 Apr 24
S-1/A
IPO registration (amended)
3 Apr 24
S-1
IPO registration
19 Mar 24
S-1
IPO registration
29 Jan 24
Proxies
DEF 14A
Definitive proxy
5 Feb 24
PRE 14A
Preliminary proxy
25 Jan 24
DEFA14A
Additional proxy soliciting materials
13 Nov 23
DEF 14A
Definitive proxy
13 Nov 23
PRE 14A
Preliminary proxy
2 Nov 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
13 May 22
DEF 14A
Definitive proxy
13 May 22
Other
EFFECT
Notice of effectiveness
18 Apr 24
EFFECT
Notice of effectiveness
9 Apr 24
EFFECT
Notice of effectiveness
22 Nov 23
CORRESP
Correspondence with SEC
17 Nov 23
UPLOAD
Letter from SEC
16 Nov 23
CERT
Certification of approval for exchange listing
16 Aug 23
EFFECT
Notice of effectiveness
15 Aug 23
CORRESP
Correspondence with SEC
11 Aug 23
CORRESP
Correspondence with SEC
28 Jul 23
UPLOAD
Letter from SEC
11 Jul 23
Ownership
SC 13G
INTRACOASTAL CAPITAL, LLC
17 Apr 24
SC 13D/A
Hare Joshua
15 Apr 24
4
Joshua Hare
12 Apr 24
4
Mohamed Wa'el Ahmed Hashad
12 Apr 24
4
Rock Soffer
12 Apr 24
4
Mohamed Wa'el Ahmed Hashad
20 Mar 24
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 24
4
Mohamed Wa'el Ahmed Hashad
2 Feb 24
4
Lisa Locklear
25 Jan 24
4
Mohamed Wa'el Ahmed Hashad
25 Jan 24